MYH10 and hepatocellular carcinoma: Additionally, Kaplan–Meier survival analyses of HCC patients from TCGA‐LIHC cohort based on the MYH10 mRNA expression suggested worse OS (p = 0.031, HR = 1.51; Figure 2H) and DFS (p = 0.017, HR = 1.58; Figure 2H) in the patients with lower MYH10 expression levels than those with high expression levels.